Related Conditions

March 26, 2024

Which Comes First – Cardiovascular Disease or Psoriasis?

“Patients with psoriasis have a lot of undiagnosed and untreated cardiovascular risk factors” per renowned dermatologist Dr. Joel Gelfand, Director, Psoriasis & Phototherapy Treatment Center at Penn. Hear why with moderator Dr. Guy Eakin, NPF Chief Scientific & Medical Officer, as they discuss risks, and what interventions using a centralized care coordination model (CP3) can do.


Psound Bytes Ep.172 "Is Choosing the Mediterranean Diet Right For You and Your Psoriatic Disease?”

This episode is provided with support from Bristol Myers Squibb.

Joel Gelfand, M.D., MSCE, and Guy Eakin, Ph.D.

CP3 Study

Increasing the lifespan and health of individuals living with psoriatic disease through personalized cardiovascular disease prevention care.

Learn about the CP3 Study


Song WB, Soffer DE, Gelfand JM. Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis. Dermatologic Clinics. Published online February 2024. doi:10.1016/j.det.2024.02.008 (Download PDF)

Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.